These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 25582534)

  • 1. CD30(+) cutaneous lymphoproliferative disorders with pseudocarcinomatous hyperplasia are associated with a T-helper-17 cytokine profile and infiltrating granulocytes.
    Guitart J; Martinez-Escala ME; Deonizio JM; Gerami P; Kadin ME
    J Am Acad Dermatol; 2015 Mar; 72(3):508-15. PubMed ID: 25582534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermal pseudocarcinomatous hyperplasia with underlying epidermal growth factor-producing cutaneous CD30-positive lymphoproliferative disorder.
    Kawachi Y; Taguchi S; Fujisawa Y; Furuta J; Nakamura Y; Ishii Y; Takahashi T; Otsuka F
    J Eur Acad Dermatol Venereol; 2009 Feb; 23(2):181-3. PubMed ID: 18429982
    [No Abstract]   [Full Text] [Related]  

  • 3. Characterization of the tumor microenvironment in primary cutaneous CD30-positive lymphoproliferative disorders: a predominance of CD163-positive M2 macrophages.
    De Souza A; Tinguely M; Burghart DR; Berisha A; Mertz KD; Kempf W
    J Cutan Pathol; 2016 Jul; 43(7):579-88. PubMed ID: 27080437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous CD30-positive lymphoproliferative disorders with CD8 expression: a clinicopathologic study of 21 cases.
    Plaza JA; Feldman AL; Magro C
    J Cutan Pathol; 2013 Feb; 40(2):236-47. PubMed ID: 23189966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary cutaneous CD30 anaplastic large cell lymphoma with keratoacanthoma-like pseudocarcinomatous hyperplasia and marked eosinophilia and neutrophilia.
    Lin JH; Lee JY
    J Cutan Pathol; 2004 Jul; 31(6):458-61. PubMed ID: 15186435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperplasia of hair follicles and other adnexal structures in cutaneous lymphoproliferative disorders: a study of 53 cases, including so-called pseudolymphomatous folliculitis and overt lymphomas.
    Kazakov DV; Belousova IE; Kacerovska D; Sima R; Vanecek T; Vazmitel M; Pizinger K; Michal M
    Am J Surg Pathol; 2008 Oct; 32(10):1468-78. PubMed ID: 18685486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benign atypical intravascular CD30(+) T-cell proliferation: a reactive condition mimicking intravascular lymphoma.
    Riveiro-Falkenbach E; Fernández-Figueras MT; Rodríguez-Peralto JL
    Am J Dermatopathol; 2013 Apr; 35(2):143-50. PubMed ID: 23542715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pityriasis lichenoides et varioliformis acuta with numerous CD30(+) cells: a variant mimicking lymphomatoid papulosis and other cutaneous lymphomas. A clinicopathologic, immunohistochemical, and molecular biological study of 13 cases.
    Kempf W; Kazakov DV; Palmedo G; Fraitag S; Schaerer L; Kutzner H
    Am J Surg Pathol; 2012 Jul; 36(7):1021-9. PubMed ID: 22472952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudocarcinomatous change in lymphomatoid papulosis and primary cutaneous CD30+ lymphoma: a clinicopathologic and immunohistochemical study of 6 patients.
    Scarisbrick JJ; Calonje E; Orchard G; Child FJ; Russell-Jones R
    J Am Acad Dermatol; 2001 Feb; 44(2):239-47. PubMed ID: 11174381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis in CD30-positive lymphoproliferative disorders of the skin.
    Greisser J; Doebbeling U; Roos M; Mueller B; Schmid M; Burg G; Kadin ME; Kempf W
    Exp Dermatol; 2005 May; 14(5):380-5. PubMed ID: 15854132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired ichthyosis associated with primary cutaneous CD30+ lymphoproliferative disorders.
    López Aventín D; Gallardo F; Yébenes M; Lloreta J; Pujol RM
    Eur J Dermatol; 2014; 24(1):105-6. PubMed ID: 24491290
    [No Abstract]   [Full Text] [Related]  

  • 12. Expression of chemokines and chemokine receptors in cutaneous CD30+ lymphoproliferative disorders.
    Yamaguchi T; Ohshima K; Karube K; Kawano R; Nakayama J; Suzumiya J; Kikuchi M
    Br J Dermatol; 2006 May; 154(5):904-9. PubMed ID: 16634894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD30+ cell population in common keratoacanthomas: a study of 21 cases.
    Fernandez-Flores A
    Rom J Morphol Embryol; 2008; 49(2):159-62. PubMed ID: 18516321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudocarcinomatous Hyperplasia Hiding Lymphomatoid Papulosis: A "Low-Power View" Pitfall.
    Bellafiore S; Grenzi L; Simonetti V; Piana S
    Int J Surg Pathol; 2016 May; 24(3):232-6. PubMed ID: 26711583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD30+ T cell enriched primary cutaneous CD4+ small/medium sized pleomorphic T cell lymphoma: A distinct variant of indolent CD4+ T cell lymphoproliferative disease.
    Magro CM; Olson LC; Fulmer CG
    Ann Diagn Pathol; 2017 Oct; 30():52-58. PubMed ID: 28965629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic and prognostic evaluation of phenotypic markers TRAF1, MUM1, BCL2 and CD15 in cutaneous CD30-positive lymphoproliferative disorders.
    Benner MF; Jansen PM; Meijer CJ; Willemze R
    Br J Dermatol; 2009 Jul; 161(1):121-7. PubMed ID: 19416236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudocarcinomatous hyperplasia in anaplastic large cell lymphoma, a mimicker of poorly differentiated squamous cell carcinoma: report of a case and review of the literature.
    Price A; Miller JH; Junkins-Hopkins JM
    J Cutan Pathol; 2015 Nov; 42(11):863-9. PubMed ID: 26040921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD30 ligand/CD30 plays a critical role in Th17 differentiation in mice.
    Sun X; Yamada H; Shibata K; Muta H; Tani K; Podack ER; Yoshikai Y
    J Immunol; 2010 Aug; 185(4):2222-30. PubMed ID: 20639486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD30-positive T-cell lymphoproliferative disorder of the oral mucosa--an indolent lesion: report of 4 cases.
    Agarwal M; Shenjere P; Blewitt RW; Hall G; Sloan P; Pigadas N; Banerjee SS
    Int J Surg Pathol; 2008 Jul; 16(3):286-90. PubMed ID: 18387994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD30+ lymphoproliferative disorders of the skin: still an open question.
    Alaibac M; Zarian H; Russo I; Peserico A
    G Ital Dermatol Venereol; 2012 Dec; 147(6):545-52. PubMed ID: 23149700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.